Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort-Reference-Cited by-同舟云学术

Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort

Published:2023-04-20 Issue:6 Volume:102 Page:1409-1420
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Cattaneo Daniele^ORCID,Bucelli Cristina,Marchetti Alfredo,Lionetti Marta,Fermo Elisa,Bellani Valentina,De Magistris Claudio,Maeda Akihiro,Marella Alessio,Primignani Massimo,Consonni Dario,Gianelli Umberto,Neri Antonino,Baldini Luca,Bolli Niccolò,Iurlo Alessandra

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05217-2.pdf

Reference74 articles.

1. Barbui T, Carobbio A, Cervantes F et al (2010) Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 115:778–782

2. Falanga A, Marchetti M (2012) Thrombotic disease in the myeloproliferative neoplasms. Hematology (Am Soc Hematol Educ Program) 2012:571–581

3. Harrison CN, Campbell PJ, Buck G et al (2005) Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 353:33–45

4. Gisslinger H, Gotic M, Holowiecki J et al (2013) Anagrelide compared to hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood 121:1720–1728

5. Carobbio A, Thiele J, Passamonti F et al (2011) Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood 117:5857–5859

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases;Clinical and Experimental Medicine;2024-07-23

2. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study;American Journal of Clinical Pathology;2024-04-10

3. Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment;Hämostaseologie;2024-02-14

4. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations;Thrombosis Research;2024-02

5. Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights;International Journal of Molecular Sciences;2024-01-26